Skip to main content


Page 3 of 5

  1. The relationship between drug use and traumatic injury is well documented, yet only a small proportion of patients are biochemically tested for cannabis and other substances. The study objective was to determi...

    Authors: Kristin Salottolo, Emmett McGuire, Robert Madayag, Allen H. Tanner II, Matthew M. Carrick and David Bar-Or
    Citation: Journal of Cannabis Research 2022 4:29
  2. The legalization of hemp in the USA has led to tremendous growth in the availability of hemp-derived products, particularly cannabidiol (CBD) products. The lack of regulatory oversight in this industry has res...

    Authors: Erin Johnson, Michael Kilgore and Shanna Babalonis
    Citation: Journal of Cannabis Research 2022 4:28
  3. Nonalcoholic fatty liver disease (NAFLD) is associated with metabolic syndrome, which often includes obesity, diabetes, and dyslipidemia. Several studies in mice and humans have implicated the involvement of t...

    Authors: Jonathan Gorelick, Tal Assa-Glazer, Gil Zandani, Anna Altberg, Noa Sela, Abraham Nyska and Zecharia Madar
    Citation: Journal of Cannabis Research 2022 4:27
  4. Cannabis is increasingly used for medical purposes, particularly in countries like Canada where cannabis was recently legalized for recreational use. We aimed to assess self-medication with cannabis post-canna...

    Authors: Antoine Asselin, Olivier Beauparlant Lamarre, Richard Chamberland, Sarah-Jeanne McNeil, Eric Demers and Arsène Zongo
    Citation: Journal of Cannabis Research 2022 4:26
  5. With increased legalization of cannabis, users are combining cannabis with exercise. The purpose of this study is to understand how and why people use cannabis when participating in physical activity.

    Authors: Whitney L. Ogle, Gregg J. Gold, Lukas E. Coppen and Claire Copriviza
    Citation: Journal of Cannabis Research 2022 4:24
  6. Because cannabinoids are usually amorphous solids, the thought that some of them may also exist in distinctly different crystal polymorphic forms might at first seem unusual. However, this commentary provides ...

    Authors: Crist N. Filer
    Citation: Journal of Cannabis Research 2022 4:23
  7. The Canadian Cannabis Act came into effect on October 17, 2018, which allowed Canadian adults to consume cannabis for non-medical purposes (Government of Canada, Cannabis regulations (SOR/2018-144). Cannabis A...

    Authors: Maisam Najafizada, Arifur Rahman, Jennifer Donnan, Zhihao Dong and Lisa Bishop
    Citation: Journal of Cannabis Research 2022 4:22
  8. Among pathways involved in the pathogenesis of coronavirus disease 2019 (COVID-19), impaired endothelial cell (EC) function and angiogenesis have been discussed less frequently than others such as cytokine sto...

    Authors: Nazanin Ashtar Nakhaei, Andisheh Najarian, Mohammad Hosein Farzaei and Amir Hossein Norooznezhad
    Citation: Journal of Cannabis Research 2022 4:21
  9. The US guidelines recommend avoiding marijuana during breastfeeding given concerns about infant’s neurodevelopment. In this setting, some physicians and hospitals recommend against or prohibit breastfeeding wh...

    Authors: Marielle S. Gross, Margot Le Neveu, Kara A. Milliken and Mary Catherine Beach
    Citation: Journal of Cannabis Research 2022 4:20
  10. Organic solvents are used for manufacturing herbal medicines and can be detected as residues of such processing in the final products. It is important for the safety of consumers to control these solvent resid...

    Authors: Hendrik Jacobus Viviers, Anél Petzer and Richard Gordon
    Citation: Journal of Cannabis Research 2022 4:19
  11. Cannabis social equity programs intend to redress inequities experienced by low income and Black, Indigenous, and People of Color (BIPOC) during cannabis prohibition in the United States. In Los Angeles County...

    Authors: Caislin L. Firth, Kristin M. Warren, Lilian Perez, Beau Kilmer, Regina A. Shih, Joan S. Tucker, Elizabeth J. D’Amico and Eric R. Pedersen
    Citation: Journal of Cannabis Research 2022 4:18
  12. Over-consumption is a common adverse outcome from cannabis edibles. States such as Colorado require each serving of cannabis edible to carry a THC symbol. This study aimed to test whether packaging edibles in ...

    Authors: Samantha Goodman and David Hammond
    Citation: Journal of Cannabis Research 2022 4:17
  13. Cannabis use among pregnant women has increased. We surveyed pregnant women in rural Pennsylvania to examine cannabis use and opinions regarding its safety during pregnancy. We examined associations between ch...

    Authors: Mohamed A. Satti, Eda G. Reed, Elizabeth S. Wenker, Stephanie L. Mitchell, Jay Schulkin, Michael L. Power and A. Dhanya Mackeen
    Citation: Journal of Cannabis Research 2022 4:16
  14. The main biological activities of cannabis are due to the presence of several compounds known as cannabinoids. Delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) are two of the main cannabinoids. Studies...

    Authors: Tameika R. James, Andrea A. Richards, Dwight A. Lowe, Walton A. Reid, Charah T. Watson and Dagogo J. Pepple
    Citation: Journal of Cannabis Research 2022 4:15
  15. Cannabis legalization has resulted in the proliferation of cannabis products. Participants’ familiarity with terms for these products may have implications for assessment, as unfamiliarity with particular term...

    Authors: S. Berberian, M. L. Broussard, C. Tully, V. Methuku, D. A. Pardini and M. H. Meier
    Citation: Journal of Cannabis Research 2022 4:14
  16. Marijuana (Cannabis sativa) is the most commonly used illicit drug in the USA, and the use of DNA barcodes could assist drug trafficking investigations by indicating the biogeographical origin and crop type of a ...

    Authors: Madeline G. Roman, Ryan Gutierrez and Rachel Houston
    Citation: Journal of Cannabis Research 2022 4:13
  17. Δ9-tetrahydrocannabinol (THC) is the main psychoactive component and one of the most important medicinal compounds in cannabis. Whether in human body fluids and breath or in laboratory and field samples, rapid a....

    Authors: Kaveh Amini, Ali Sepehrifard, Ali Valinasabpouri, Jennifer Safruk, Davide Angelone and Tiago de Campos Lourenco
    Citation: Journal of Cannabis Research 2022 4:12

    The Correction to this article has been published in Journal of Cannabis Research 2022 4:38

  18. We undertook this systematic review to determine the efficacy and safety of cannabis-based medicine as a treatment for behavioral, psychological, and motor symptoms associated with neurocognitive disorders.

    Authors: Anees Bahji, Natasha Breward, Whitney Duff, Nafisa Absher, Scott B. Patten, Jane Alcorn and Darrell D. Mousseau
    Citation: Journal of Cannabis Research 2022 4:11
  19. The current revision to Thailand’s Narcotics Act (B.E. 2563) permits Thai corporations to produce cannabis (ganja) for therapeutic purposes, as well as conduct beneficial research and development in science an...

    Authors: Sarana Rose Sommano, Tibet Tangpao, Tanachai Pankasemsuk, Voranate Ponpanumas, Yuthana Phimolsiripol, Pornchai Rachtanapun and Shashanka K. Prasad
    Citation: Journal of Cannabis Research 2022 4:10
  20. When non-medical cannabis use became legal, government regulators implemented policies to encourage safer consumption through access to a regulated market. While this market is growing, sales still occur throu...

    Authors: Jennifer Donnan, Omar Shogan, Lisa Bishop, Michelle Swab and Maisam Najafizada
    Citation: Journal of Cannabis Research 2022 4:9
  21. The wide heterogeneity of available cannabis products makes it difficult for physicians to appropriately guide patients. In the current study, our objective was to characterize naturalistic cannabis use routin...

    Authors: Kevin F. Boehnke, Laura Yakas, J. Ryan Scott, Melissa DeJonckheere, Evangelos Litinas, Suzanne Sisley, Daniel J. Clauw, David A. Williams and Jenna McAfee
    Citation: Journal of Cannabis Research 2022 4:7
  22. A case of an 85-year-old patient with concurrent use of warfarin and medical cannabis containing delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) is described. Warfarin continues to be a cornerstone of...

    Authors: Tyan F. Thomas, Evdokia S. Metaxas, Thu Nguyen, Whitni Bennett, Kathryn V. Skiendzielewski, Diane H. Quinn and Alice L. Scaletta
    Citation: Journal of Cannabis Research 2022 4:6
  23. As the legalization of cannabis moves forward in many countries, it is important to highlight the potential harm that excessive use can cause on young consumers. Crafting effective policy interventions to redu...

    Authors: Salvador Espinosa, Charles Marks and Gustavo Fondevila
    Citation: Journal of Cannabis Research 2022 4:5
  24. Products containing delta-8-THC became widely available in most of the USA following the 2018 Farm Bill and by late 2020 were core products of hemp processing companies, especially where delta-9-THC use remain...

    Authors: Jessica S. Kruger and Daniel J. Kruger
    Citation: Journal of Cannabis Research 2022 4:4
  25. Palliative care aims to improve quality of life through optimal symptom control and pain management. Cannabis-based medicinal products (CBMPs) have a proven role in the treatment of chemotherapy-induced nausea an...

    Authors: Devaki Nimalan, Michal Kawka, Simon Erridge, Mehmet Ergisi, Michael Harris, Oliver Salazar, Rayyan Ali, Katerina Loupasaki, Carl Holvey, Ross Coomber, Michael Platt, James J. Rucker, Shaheen Khan and Mikael H. Sodergren
    Citation: Journal of Cannabis Research 2022 4:3
  26. Cannabigerolic acid (CBGA), a precursor cannabinoid in Cannabis sativa, has recently been found to have anticonvulsant properties in the Scn1a+/- mouse model of Dravet syndrome. Poor brain penetration and chemica...

    Authors: Lyndsey L. Anderson, Michael Udoh, Declan Everett-Morgan, Marika Heblinski, Iain S. McGregor, Samuel D. Banister and Jonathon C. Arnold
    Citation: Journal of Cannabis Research 2022 4:2
  27. Cannabis sativa L. produces at least 120 cannabinoids. Although genetic variation is the main factor in cannabinoid production, the effects of short-term environmental stresses in the early flowering stage remain...

    Authors: Sang-Hyuck Park, Christopher S. Pauli, Eric L. Gostin, S. Kyle Staples, Dustin Seifried, Chad Kinney and Brian D. Vanden Heuvel
    Citation: Journal of Cannabis Research 2022 4:1
  28. Autism spectrum disorder is a neurodevelopmental disorder characterized by deficits in communication, social interaction, restricted interest, and repetitive behaviors. Although more cases are being diagnosed,...

    Authors: Serap Bilge and Barış Ekici
    Citation: Journal of Cannabis Research 2021 3:53
  29. Cannabidiol (CBD) is now a legal substance in Europe and is available in ‘high street shops’, usually as CBD oil. However, in the United Kingdom (UK), there is no clear consensus among healthcare professionals...

    Authors: Obioha Ukaegbu, Jared Smith, David Hall, Thomas Frain and Cyrus Abbasian
    Citation: Journal of Cannabis Research 2021 3:51
  30. Pesticide testing for hemp has traditionally focused on techniques like QuEChERS with dSPE and SPE which demand time-consuming sample preparation, typically resulting in poor recovery rates for some pesticides...

    Authors: Avinash Dalmia, Erasmus Cudjoe, Jacob Jalali and Feng Qin
    Citation: Journal of Cannabis Research 2021 3:50
  31. The United States Food and Drug Administration (FDA) monitors, inspects, and enforces the promotion of products by companies that claim to mitigate, prevent, treat, diagnose, or cure COVID-19. The introduction...

    Authors: Allan Tran, Natasha Y. Sheikhan, Tania Sheikhan, Dominik A. Nowak and Theodore J. Witek Jr
    Citation: Journal of Cannabis Research 2021 3:49
  32. Medicinal cannabis has been legalised for use for a range of specified medical conditions in Australia since 2016. However, the nature of the government regulations and the subsequent complexity of prescribing...

    Authors: Monique Lewis and John Flood
    Citation: Journal of Cannabis Research 2021 3:48

    The Correction to this article has been published in Journal of Cannabis Research 2021 3:52

  33. Recently, the renewed global interest in cannabis’ therapeutic properties has resulted in shifting attitudes and legislative policies worldwide. The aim of this systematic review is to explore the existing lit...

    Authors: Jared M. Weisman and Marcus Rodríguez
    Citation: Journal of Cannabis Research 2021 3:47
  34. Acute respiratory distress syndrome (ARDS) is a life-threatening clinical syndrome whose potential to become one of the most grievous challenges of the healthcare system evidenced by the COVID-19 pandemic. Con...

    Authors: Hesam Khodadadi, Évila Lopes Salles, Eunice Shin, Abbas Jarrahi, Vincenzo Costigliola, Pritesh Kumar, Jack C. Yu, John C. Morgan, David C. Hess, Kumar Vaibhav, Krishnan M. Dhandapani and Babak Baban
    Citation: Journal of Cannabis Research 2021 3:45
  35. Whole-plant cannabis extracts are consumed by the public for medical and non-medical (“recreational”) purposes but are poorly researched compared to pure cannabinoids. There is emerging evidence that cannabis ...

    Authors: Jessica Nixon, Hanan Abramovici, Ashley Cabecinha, Camilo Martinez-Farina, Joseph Hui and Lee Ellis
    Citation: Journal of Cannabis Research 2021 3:44
  36. The effects of cannabis use on male and female reproduction have been the focus of scientific research for decades. Although initial studies raised concerns, more recent studies were reassuring. Considering th...

    Authors: Eden Har-Gil, Ayala Heled, Marjorie Dixon, Abdul Munaf Sultan Ahamed and Yaakov Bentov
    Citation: Journal of Cannabis Research 2021 3:42
  37. Chronic musculoskeletal pain (CMP) may lead to reduced physical function and is the most common cause of chronic non-cancer pain. Currently, the pharmacotherapeutic options against CMP are limited and frequent...

    Authors: Daniela Furrer, Edeltraut Kröger, Martine Marcotte, Nathalie Jauvin, Richard Bélanger, Mark Ware, Guillaume Foldes-Busque, Michèle Aubin, Pierre Pluye and Clermont E. Dionne
    Citation: Journal of Cannabis Research 2021 3:41
  38. Cannabinoids are increasingly becoming compounds of medical interest. However, cannabis plants only produce carboxylated cannabinoids. In order to access the purported medical benefits of these compounds, the ...

    Authors: Kenneth J. Olejar and Chad A. Kinney
    Citation: Journal of Cannabis Research 2021 3:40
  39. Understanding similarities, differences, and associations between reasons people vape nicotine and cannabis may be important for identifying underlying contributors to their co-use.

    Authors: Danielle M. Smith, Lynn Kozlowski, Richard J. O’Connor, Andrew Hyland and R. Lorraine Collins
    Citation: Journal of Cannabis Research 2021 3:39
  40. Lipid profile and redox status play a role in brain (dys)functions. Cannabinoid and melatonergic systems operate in the brain and contribute to brain (patho)physiology, but their roles in the modulation of bra...

    Authors: Halimat Amin Abdulrahim, Isiaka Abdullateef Alagbonsi, Oluwasola Amuda, Noah Adavize Omeiza, Abdul-Rahuf Aderemi Feyitimi and Luqman Aribidesi Olayaki
    Citation: Journal of Cannabis Research 2021 3:38
  41. Since the legalization of medical marijuana (MMJ) in Ohio in 2018, many chronic pain (CP) patients have become interested in it as an alternative or adjunct to prescription opioids. This has not only created a...

    Authors: Daniel Adams, Nana Ama Ofei-Tenkorang, Patrick Connell, Alexa Owens, Aaron Gothard, Dmitri Souza and Samer Narouze
    Citation: Journal of Cannabis Research 2021 3:37
  42. Cannabis has increasingly become an alternative treatment for chronic pain, however, there is evidence of concomitant negative health effects with its long-term usage. Patients contemplating cannabis use for p...

    Authors: Jeremy Y. Ng, Darragh A. Dzisiak and Jessica B. Saini
    Citation: Journal of Cannabis Research 2021 3:36
  43. Despite repeated calls by medical associations to gather evidence on the harms and benefits of cannabis, there are ongoing methodological challenges to conducting observational and clinical studies on cannabis...

    Authors: Philippe Lucas, Susan Boyd, M.-J. Milloy and Zach Walsh
    Citation: Journal of Cannabis Research 2021 3:34
  44. Despite decreasing consumption by general populations, use of synthetic cannabinoid receptor agonists (SCRAs) persists in some marginalised groups, including those who use other substances. This article explor...

    Authors: Melissa A. Jackson, Amanda L. Brown, Jennifer Johnston, Richard Clancy, Iain McGregor, Raimondo Bruno, Nick Lintzeris, Mark Montebello, Jennifer Luksza, Jenny Bowman, Nghi Phung, Dave Allsop and Adrian J. Dunlop
    Citation: Journal of Cannabis Research 2021 3:33

Affiliated with

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 4.1
    5-year Journal Impact Factor: 3.8
    Source Normalized Impact per Paper (SNIP): 0.894
    SCImago Journal Rank (SJR): 0.692

    Speed 2023
    Submission to first editorial decision (median days): 22
    Submission to acceptance (median days): 211

    Usage 2023
    Downloads: 596,678
    Altmetric mentions: 1,834